Blood from systemic lupus erythematosus (SLE) patients and healthy individuals (NHS) was analyzed for antibodies to Z-DNA using ELISA with brominated poly(dGdC) as an antigen. Both groups exhibited Z-DNA antibody binding. In SLE patients, antibody levels to Z-DNA correlated with B-DNA antibodies, indicating cross-reactivity confirmed through DNA cellulose adsorption experiments. Ionic strength affected SLE anti-Z-DNA antibody binding, implying electrostatic interactions. These findings suggest that SLE anti-DNA antibody responses might be triggered by bacterial DNA, potentially due to cross-reactivity with Z-DNA found in bacterial DNA and biofilms.
Related Posts
Decoding miscarriages: Genome haplarithmisis reveals intricate genetic puzzles
Scientists are using a special tool called “genome haplarithmisis” to investigate why some pregnancies face challenges. It’s like a DNA detective, delving into the intricacies of our genetic instructions to unravel the mysteries behind miscarriages. This tool helps them decipher the complex genetic landscape associated with pregnancy complications. By piecing together these genetic details, scientists […]
Why journal articles face rejection?
When a manuscript is submitted to a journal, it undergoes a thorough quality check under the peer review process before being sent to the chief editor. Most articles face rejection during this process. There are several reasons for this. 1. The article is beyond the scope of the journal Your article can be immediately rejected […]
Cancer Therapy Success Relies on Inducing Apoptosis: Understanding the Vital Role of Programmed Cell Death in Treatment.
After cancer cells are killed by treatments like chemotherapy or radiation, they typically undergo a process known as apoptosis or programmed cell death. This is a natural mechanism in the body that recognizes damaged or abnormal cells and triggers their self-destruction. In the case of cancer cells, these treatments induce apoptosis, causing the cells to […]